After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast enough to save the sick?
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Breakthrough Energy, the Bill Gates-backed group that bankrolls climate tech, has stopped making new investments from one of its key funds to scale up nascent green technologies, just as the market ...
The squishy insoles in your favorite pair of sneakers help keep your joints safe from daily wear-and-tear, but over time, that cushioning wears down. The same goes for your cartilage—the fibrous ...
Pope Leo XIV gives his blessing at the conclusion of his weekly general audience in the Paul VI Audience Hall at the Vatican Feb. 11, 2026. Credit: CNS photo/Lola Gomez The following is the text from ...
Pope Leo XIV greets people at the conclusion of his weekly general audience in the Paul VI Audience Hall at the Vatican Feb. 4, 2026. Credit: CNS photo/Vatican Media The following is the text from ...
Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...
Scientists have created a device that captures carbon dioxide and transforms it into a useful chemical in a single step. The new electrode works with realistic exhaust gases rather than requiring ...
Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...
Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in development to treat certain ovarian cancer patients. The Indianapolis-based ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results